We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.84B
Cap. Flow %
34.3%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 16.38%
3 Financials 13.99%
4 Communication Services 7.66%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISLEW
826
DELISTED
Isleworth Healthcare Acquisition Corporation Warrant
ISLEW
$69K ﹤0.01%
99,999
TLSIW icon
827
TriSalus Life Sciences Warrant
TLSIW
$40.7M
$67K ﹤0.01%
66,664
BTMDW
828
DELISTED
Biote Corp. Warrant
BTMDW
$64K ﹤0.01%
+62,541
New +$54.1K
XLF icon
829
CALL
State Street Financial Select Sector SPDR ETF
XLF
$58.1B
$62K ﹤0.01%
650,000
-1,350,000
-68% -$49.4M
IACB.WS
830
DELISTED
ION Acquisition Corp 2 Ltd. Warrants, each whole warrant exercisable for one Class A ordinary share
IACB.WS
$56K ﹤0.01%
+31,250
New +$42.7K
RUMBW
831
RUM Group Inc Warrant
RUMBW
$13.8M
$50K ﹤0.01%
+50,000
New +$44.9K
SDSTW
832
Stardust Power Inc Warrant
SDSTW
$5.67M
$45K ﹤0.01%
41,665
GNCA
833
DELISTED
Genocea Biosciences, Inc.
GNCA
$45K ﹤0.01%
19,170
LMACW
834
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
$44K ﹤0.01%
19,999
TRN icon
835
PUT
Trinity Industries
TRN
$2.39B
$42K ﹤0.01%
+15,500
New +$437K
AMC icon
836
PUT
AMC Entertainment Holdings
AMC
$2.29B
$39K ﹤0.01%
22,980
+10,480
+84% +$2.78M
MAXR
837
PUT
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$35K ﹤0.01%
+15,000
New +$534K
OMF icon
838
PUT
OneMain Financial
OMF
$7.48B
$32K ﹤0.01%
+15,400
New +$872K
RDN icon
839
PUT
Radian Group
RDN
$4.93B
$32K ﹤0.01%
+22,600
New +$528K
CHAA.WS
840
DELISTED
Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHAA.WS
$31K ﹤0.01%
+33,333
New +$25.7K
LTHM
841
PUT
DELISTED
Livent Corporation
LTHM
$30K ﹤0.01%
300,000
MGP
842
PUT
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$21K ﹤0.01%
+23,500
New +$837K
BLMN icon
843
PUT
Bloomin' Brands
BLMN
$932M
$19K ﹤0.01%
75,000
CLF icon
844
PUT
Cleveland-Cliffs
CLF
$6.98B
$19K ﹤0.01%
60,000
MAT icon
845
PUT
Mattel
MAT
$4.29B
$16K ﹤0.01%
91,300
CNX icon
846
PUT
CNX Resources
CNX
$5.2B
$8K ﹤0.01%
47,500
AMLP icon
847
Alerian MLP ETF
AMLP
$12.8B
-75,000
Closed -$2.29M
ASTS icon
848
AST SpaceMobile
ASTS
$21.5B
-1,505,873
Closed -$17.6M
BDN
849
Brandywine Realty Trust
BDN
$556M
-124,486
Closed -$1.61M
BILL icon
850
BILL Holdings
BILL
$4.77B
-10,725
Closed -$1.56M

Similar funds

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.84B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.